I would not support this strategy unless the patient is on longer term ADT for biochemical recurrence after prior local therapy. In that setting, intermittent ADT is a viable option supported by literature and could be considered. Otherwise, once ADT is stopped, there's no basis for resuming. The c...

For someone on LT-ADT for definitive management of prostate cancer, I presume they are receiving a total of 18-36 months of therapy. The concept of ADT is to keep the patient in a castrated state throughout this duration of time, and to do it in a manner that can be reversed by cessation of medicati...

I'd tell the patient it comes down to whether they think the ADT is doing something to help their cancer treatment or not. If the answer is "yes", then why would they want to wait until they were sure it wasn't doing anything before delivering it again? If the answer was "no", why take it at all? A...